Literature DB >> 16769951

A clinical score for prognosis of status epilepticus in adults.

Andrea O Rossetti1, Giancarlo Logroscino, Edward B Bromfield.   

Abstract

The authors derived a clinical score to predict mortality in status epilepticus (SE) from analysis of a retrospective SE cohort, using four variables available at presentation: history of seizures, age, seizure type, and consciousness impairment. Validation on a small prospective SE series (34 patients) resulted in sensitivity, 1.000; specificity, 0.643; negative predictive value, 1.000; and unweighted accuracy, 0.822. This simple clinical score may reliably identify patients surviving after SE.

Entities:  

Mesh:

Year:  2006        PMID: 16769951     DOI: 10.1212/01.wnl.0000223352.71621.97

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

Review 1.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

2.  Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety.

Authors:  Flavio Bellante; Benjamin Legros; Chantal Depondt; Jacques Créteur; Fabio Silvio Taccone; Nicolas Gaspard
Journal:  J Neurol       Date:  2016-02-25       Impact factor: 4.849

Review 3.  Refractory and super-refractory status epilepticus--an update.

Authors:  Sara Hocker; William O Tatum; Suzette LaRoche; W David Freeman
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

Review 4.  Status epilepticus: an update.

Authors:  Panayiotis N Varelas; Marianna V Spanaki; Marek A Mirski
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

5.  Evaluation of STESS, mRSTESS, and EMSE to Predict High Disability and Mortality at Hospital Discharge in Ecuadorian Patients with Status Epilepticus.

Authors:  Dannys Rivero Rodríguez; Claudio Scherle Matamoros; Kimberly Sam; Daniela DiCapua Sacoto; Nelson Maldonado Samaniego; Yanelis Pernas
Journal:  Neurocrit Care       Date:  2018-12       Impact factor: 3.210

6.  Independent impact of infections on the course and outcome of status epilepticus: a 10-year cohort study.

Authors:  Saskia Semmlack; Sarah Tschudin-Sutter; Andreas F Widmer; Martina Valença; Stephan Rüegg; Stephan Marsch; Raoul Sutter
Journal:  J Neurol       Date:  2016-05-03       Impact factor: 4.849

7.  Anesthetics and Outcome in Status Epilepticus: A Matched Two-Center Cohort Study.

Authors:  Raoul Sutter; Gian Marco De Marchis; Saskia Semmlack; Peter Fuhr; Stephan Rüegg; Stephan Marsch; Wendy C Ziai; Peter W Kaplan
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

8.  Association of seizure duration and outcome in refractory status epilepticus.

Authors:  Dominik Madžar; Anna Geyer; Ruben U Knappe; Stephanie Gollwitzer; Joji B Kuramatsu; Stefan T Gerner; Hajo M Hamer; Hagen B Huttner
Journal:  J Neurol       Date:  2016-01-02       Impact factor: 4.849

9.  Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.

Authors:  Raoul Sutter; Stephan Marsch; Stephan Rüegg
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

10.  Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy.

Authors:  Andrea O Rossetti; Giancarlo Logroscino; Tracey A Milligan; Costas Michaelides; Christiane Ruffieux; Edward B Bromfield
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.